Glaxo and SmithKline Beecham face drugs sell-off to seal pounds 100bn mega-merger

Glaxo Wellcome and SmithKline Beecham are expected to sell some of their best-selling drugs in order to avoid a full-scale regulatory inquiry into their proposed pounds 100bn mega-merger. Meanwhile unions are asking the Government to block the deal, which they fear could lead to the loss of 10,000 jobs in the UK. Nigel Cope, City Correspondent, reports.

Disposals are likely in two areas of therapeutic drugs where Glaxo and SmithKline dominate their markets. In anti-viral drugs, used to treat infections such as Herpes, Glaxo markets the highly successful Zovirax and Valtrex while SmithKline has Famvir.

In drugs used to combat nausea caused from chemotherapy, Glaxo and SmithKline dominate the market with Zofran and Kytril respectively. The two companies expect they will have to make disposals in these areas in order to satisfy the competition authorities that consumer choice would be protected and that a position of market dominance would not be used to raise prices.

There is a parallel with the Glaxo takeover of Wellcome in 1995, when both companies had migraine treatments in late stages of development. Glaxo sold its drug to Zeneca.

The deal will be scrutinised by the Federal Trade Commission in the US and the European Commission in the European Union. However, it is possible that the UK competition authorities could seek to gain a role in the inquiry process.

Though a merged Glaxo-Wellcome and SmithKline Beecham would be a UK company with its base in London, unions have reacted angrily to the prospect of widescale redundancies here. They fear up to 10,000 job cuts as part of a pounds 1bn cost-cutting programme and say it will reduce the country's pool of skilled scientists, hit competition and reduce consumer choice. Roger Lyons, the general secretary of the MSF, the manufacturing, science and finance union, said: "Our concern is that the only advantage of the deal is in cutting costs by shedding jobs." The union is calling for urgent meetings with Margaret Beckett, President of the Board of Trade, as well as MEPs and both companies.

The biggest threat to jobs is at the two groups' head offices and sales and marketing centres. Glaxo's head office is in Greenford while SmithKline employs almost 2,000 people in head office and sales functions at several offices in Brentford.

It is not clear whether the group's main research and development centres could be threatened. Glaxo opened a pounds 700m facility in Stevenage in 1995. SmithKline spent pounds 250m on a new site in Harlow, Essex, which opened last April.

Neither company would comment on possible research closures though SmithKline said: "The driving force behind this merger is that it would build a R&D function that would be second to none."

The combined research spending of the merged group would be pounds 2bn. SmithKline claims this would be double the spending of any other drugs company. Analysts estimate that the UK job loss figure could be closer to 2,000, mostly from head office and sales functions.

They were responding to the surprise announcement late on Friday that the two companies were in detailed discussions which could lead to a full scale merger. The deal would be the largest merger in corporate history and create the third-largest company in the world after General Electric of the US and Royal Dutch-Shell, the Anglo-Dutch Group. It will also be the world's largest pharmaceuticals company, leapfrogging Merck of the US.

The proposals also mean that SmithKline has dropped its plans to merger with American Home Products in a pounds 77bn deal that was only announced last week.

The terms of the deal have already been decided even though the two groups first made contact only eight days ago. Glaxo shareholders will hold 59.5 per cent of the group with SmithKline investors holding the remaining 40.5 per cent. Sir Richard Sykes, Glaxo's chairman, will be executive chairman of the combined group. Jan Leschly, chief executive of SmithKline, will be chief executive.

The merger will provide a fees bonanza for the investment banks. Lazards, which is advising Glaxo, and Morgan Stanley, which is representing SmithKline, could net fees of pounds 100m, according to some estimates.

Analysts say the merger is likely to prompt another wave off consolidation in the pharmaceuticals industry. Drug company shares are expected to soar today as traders try to spot the next bid or merger target.

Zeneca yesterday dismissed suggestions that it would be forced to seek alliances in order to combat the Glaxo-SmithKline behemoth. "The company has been very successful in developing a drug portfolio in the past few years and there is no reason why that should not continue," a spokesman said.

Zeneca has concentrated on two areas, cardio-vascular drugs and cancer treatments.

Hoechst, the German drugs group said the Glaxo merger would intensify international competition. "If the industry concentration process continues, then all industry participants will have to re-think their positioning," it said.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
News
Starting the day with a three-egg omelette could make people more charitable, according to new research
science
News
Top Gun actor Val Kilmer lost his small claims court battle in Van Nuys with the landlord of his Malibu mansion to get back his deposit after wallpapering over the kitchen cabinets
people
News
Comedian Ted Robbins collapsed on stage during a performance of Phoenix Nights Live at Manchester Arena (Rex)
people
News
The actress Geraldine McEwan was perhaps best known for playing Agatha Christie's detective, Miss Marple (Rex)
peopleShe won a Bafta in 1991 for her role in Oranges Are Not The Only Fruit
News
newsPatrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad
News
Robert Fraser, aka Groovy Bob
peopleA new show honours Robert Fraser, one of the era's forgotten players
Life and Style
Torsten Sherwood's Noook is a simple construction toy for creating mini-architecture
tech
Sport
David Silva celebrates with Sergio Aguero after equalising against Chelsea
footballChelsea 1 Manchester City 1
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Software Development Manager

£40000 - £50000 per annum: Recruitment Genius: This is an exciting opportunity...

Ashdown Group: Product Manager - (Product Marketing, Financial Services)

£30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...

Recruitment Genius: Compliance Assistant

£13000 per annum: Recruitment Genius: This Pension Specialist was established ...

Ashdown Group: Market Research Executive

£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

Day In a Page

As in 1942, Germany must show restraint over Greece

As in 1942, Germany must show restraint over Greece

Mussolini tried to warn his ally of the danger of bringing the country to its knees. So should we, says Patrick Cockburn
Britain's widening poverty gap should be causing outrage at the start of the election campaign

The short stroll that should be our walk of shame

Courting the global elite has failed to benefit Britain, as the vast disparity in wealth on display in the capital shows
Homeless Veterans appeal: The rise of the working poor: when having a job cannot prevent poverty

Homeless Veterans appeal

The rise of the working poor: when having a job cannot prevent poverty
Prince Charles the saviour of the nation? A new book highlights concerns about how political he will be when he eventually becomes king

Prince Charles the saviour of the nation?

A new book highlights concerns about how political he will be when he eventually becomes king
How books can defeat Isis: Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad

How books can defeat Isis

Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad
Judith Hackitt: The myths of elf 'n' safety

Judith Hackitt: The myths of elf 'n' safety

She may be in charge of minimising our risks of injury, but the chair of the Health and Safety Executive still wants children to be able to hurt themselves
The open loathing between Barack Obama and Benjamin Netanyahu just got worse

The open loathing between Obama and Netanyahu just got worse

The Israeli PM's relationship with the Obama has always been chilly, but going over the President's head on Iran will do him no favours, says Rupert Cornwell
French chefs get 'le huff' as nation slips down global cuisine rankings

French chefs get 'le huff' as nation slips down global cuisine rankings

Fury at British best restaurants survey sees French magazine produce a rival list
Star choreographer Matthew Bourne gives young carers a chance to perform at Sadler's Wells

Young carers to make dance debut

What happened when superstar choreographer Matthew Bourne encouraged 27 teenage carers to think about themselves for once?
Design Council's 70th anniversary: Four of the most intriguing prototypes from Ones to Watch

Design Council's 70th anniversary

Four of the most intriguing prototypes from Ones to Watch
Dame Harriet Walter: The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment

Dame Harriet Walter interview

The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment
Art should not be a slave to the ideas driving it

Art should not be a slave to the ideas driving it

Critics of Tom Stoppard's new play seem to agree that cerebral can never trump character, says DJ Taylor
Bill Granger recipes: Our chef's winter salads will make you feel energised through February

Bill Granger's winter salads

Salads aren't just a bit on the side, says our chef - their crunch, colour and natural goodness are perfect for a midwinter pick-me-up
England vs Wales: Cool head George Ford ready to put out dragon fire

George Ford: Cool head ready to put out dragon fire

No 10’s calmness under pressure will be key for England in Cardiff
Michael Calvin: Time for Old Firm to put aside bigotry and forge new links

Michael Calvin's Last Word

Time for Old Firm to put aside bigotry and forge new links